T HE CLINICAL association of obesity with the occurrence of cardiovascular disease has been extensively reported and is quite generally accepted. Yet the exact mechanism by which obesity facilitates the development of vascular disease has remained obscure, except for speculation on the possible physical burden of the excess adipose tissue. Atherosclerosis is the underlying basis for the major fraction of degenerative vascular disease. In several previous reportsl-6 concerning serum lipid transport via lipoproteins, we have established that certain special classes of lipoproteins are closely associated with the development of human atherosclerosis. It was of obvious interest to determine whether obesity is significantly related to the serum levels of atherosclerosis-associated lipoproteins, and whether any such relationship might explain the role of obesity in atherosclerogenesis. variability in serum Sf 20-100 level, it has been possible to demonstrate unequivocally6 the independent association of this class of lipoproteins with atherosclerosis to a degree essentially equivalent to that of the Sf 12-20 class of lipoproteins.
Earlier crude inspection of the data indicated that there was no marked relationship between estimated obesity and the serum Sf 12-20 lipoprotein level. In this study we have been able to make a precise evaluation of the relationship within the limits of the collected data for both the Sf 12-20 and Sf 20-100 lipoproteins with obesity. The group It is evident from the data of table 1 that there is definitely a significant positive correlation between serum Sf 35-100 lipoprotein level and estimated obesity. This is the strongest relationship with estimated obesity observed in these data. The over-all Sf 12-100 lipoprotein level correlates positively with estimated obesity nearly as well. However, a significant, but much weaker, relationship is seen between serum Sf 12-20 level and estimated obesity.
There is a trend in the same direction in the relationship of total serum cholesterol with obesity, but quantitatively this relationship While these observations bear out the earlier impression of the very low correlation of the Sf 12-20 level with estimated obesity, the slight relationship is a significant one and has bearing upon atherogenicity. The much higher relationship of the Sf 35-100 molecules with estimated obesity has real implications for atherosclerosis. Crudely, obesity accounts for approximately 8 per cent of the relationship of the S f 35-100 lipoproteins with atherosclerosis, a relationship previously demonstrated to be a reasonably high one.6 Since obesity was estimated here by height-weight relationships (at best a crude approximation to its assessment), and since there are biologic and technical variations in the estimate of the Sf 35-100 level, it is highly probable that the over-all Sf 35-100-obesity relationship is of the order of twice the measured one. This might then indicate that about 15 to 20 per cent (or more) of the relationship of the Sf 35-100 lipoproteins with atherosclerosis is accounted for by obesity. Further, since the relationship of Sf 35-100 level with obesity is only of moderate degree, we may infer that for some patients obesity is contributing far more than the estimated 15 to 20 per cent, whereas for others it contributes much less. The relationship of obesity with the other atherosclerosis-associated lipoproteins, the Sf 12-20 class, while of lesser degree than that for the Sf 35-100 class, is still appreciable and hence is of real importance for at least a segment of the population.
There are several possible explanations for the association of elevation of Sf 35-100 lipoproteins with obesity. In previous work5 we have actually observed an acute rise in level of such molecules in the first several hours following a high fat meal. 
